Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-citalopram Efficacy and Vasodilatory Response in Social Phobia
NCT00485888Phase 2Completed
- Sponsor
- START Clinic for Mood and Anxiety Disorders
- Start
- Oct 2008
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Social Anxiety Disorder (SAD) comparing S-citalopram with Placebo (2 arms). Primary endpoint: Changes in intensity of the vasodilatory response to 10 mM topical methyl-nicotinate at 16 weeks. Started Oct 2008; status: completed.
02
Drugs
escitalopram
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT00485888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00485888.